Разработка эффективного способа получения рекомбинантного белка проинсулина человека из тел включения штамм-продуцента E.coli
Диссертация
Исследовано влияние окислительно-восстановительных пар на протекание ренатурации. Использование глутатиона при различных соотношениях восстановленной и окисленной форм не привело к увеличению выхода на-тивного РБ. Для окислительно-восстановительной пары цистеин/цистин определено оптимальное соотношение, составившее от 0.1/0.5 мМ до 0.5/0.1 мМ при общей концентрации тиолов 1.0 мМ, что позволило… Читать ещё >
Содержание
- СПИСОК ИСПОЛЬЗУЕМЫХ СОКРАЩЕНИЙ
- ЛИТЕРАТУРНЫЙ ОБЗОР
- 1. Образование тел включения
- 1. 1. Особенности биосинтеза рекомбинантных эукариотических белков в бактериальных клетках
- 1. 2. Выделение тел включения
- 1. 3. Растворение тел включения
- 1. 4. Очистка растворенных белков тел включения
- 2. Ренатурация белков тел включения
- 2. 1. Удаление денатуранта
- 2. 2. Хроматографическая ренатурация
- 2. 2. 1. Эксклюзионная хроматография
- 2. 2. 2. Адсорбционная ренатурация
- 2. 2. 3. Ренатурация с иммобилизированными катализаторами фолдинга
- 2. 3. Ренатурация белков с дисульфидными связями
- 2. 4. Влияние физических факторов на ренатурацию
- 2. 5. Ренатурация с низкомолекулярными добавками
- 2. 6. Ренатурация, имитирующая процесс in vivo
- 2. 6. 1. Природные шапероны
- 2. 6. 2. Мицеллярные системы
- 2. 6. 3. Жидкий парафин как псевдолипидний бислой
- 3. 1. Методы получения рекомбинантных блков проинсулина
- 3. 2. Фолдинг рекомбинантных белков проинсулина
- 3. 2. 1. Восстановление
- 3. 2. 2. Сульфитолиз
- 3. 2. 3. Метод мини-проинсулина
- 2. 1. Получение стандартного образца мономера РБ
- 2. 2. Подбор условий аналитического разделения мономера РБ и его мультимерных форм
- 2. 2. 1. Подвижная фаза
- 2. 2. 2. Определение оптимальной скорости элюции
- 2. 3. Валидация метода анализа
- 2. 3. 1. Линейность определения концентрации РБ
- 2. 3. 2. Правильность и точность
- 2. 3. 3. Пред ел обнаружения и предел количественной оценки
- 2. 3. 4. Специфичност ь
- 2. 3. 5. Устойчивость метода
- 2. 4. Выводы
- 3. 1. Денатурация РБ: влияние хаотропного агента
- 3. 2. Денатурация РБ: рН и буферная система
- 3. 3. Денатурация РБ: концентрация восстанавливающего агента и концентрация РБ
- 4. 1. Ренатурация РБ: определение максимального выхода
- 4. 2. Ренатурация РБ: влияние внешних факторов
- 4. 3. Ренатурация РБ: концентрация РБ
- 4. 4. Ренатурация РБ: низкомолекулярные добавки
- 4. 5. Ренатурация РБ: окислительно-восстановительные пары
- 1. 1. Реактивы
- 1. 2. Хроматографические сорбенты и колонны
- 2. 1. Хроматографические системы
- 2. 2. Оборудование
- 3. 1. Контроль содержания мономера РБ методом SEC
- 3. 2. Получение рабочего стандарта РБ
- 3. 2. 1. Выделение РБ из ТВ
- 3. 2. 2. Проведение ионообменной очистки
- 3. 2. 3. Проведение ВЭЖХ-очистки
- 3. 3. Валидация SEC-анализарекомбинантного белка
- 3. 3. 1. Линейность определения концентрации РБ
- 3. 3. 2. Правильность и точность
- 3. 3. 3. Специфичность
- 3. 3. 4. Устойчивость метода
- 4. 1. Влияние хаотропного агента
- 4. 2. Влияние рН среды и буферного агента
- 4. 3. Влияние концентрации восстанавливающего агента и РБ
- 5. 1. Определение максимального выхода ренатурации
- 5. 2. Определение влияния внешних факторов на ренатурацию
- 5. 3. Определение влияния концентрации РБ на ренатурацию
- 5. 4. Влияние низкомолекулярных добавок
- 5. 5. Влияние окислительно-восстановительных пар
Список литературы
- R., Pessin J.E. eds / Mechanism of 1. sulin Action. // Springer NY 2007. P.214.2 http://wvvw.who.int/mediacentre/factsheets/fs312/ru/
- Kjeldsen T. / Yeast secretory expression of insulin precursors // Appl Microbiol Biotechnol. 2000. V.54(3). P.277−286.
- Ю.А. Овчинников / Биоорганическая химия // M: «Просвещение» 1987. стр. 41 -42, 67−68, 247−249.
- F. Sanger / Chemistry of insulin// Science 1959. V.129, P. 1340−1344.
- Kane J.F., Hartley D.L. / Properties of inclusion bodies from recombinant Escherichia coli. // Biochem Soc Trans. 1988. V.16(2). P.101−102.
- Marston F.A. O. / The purification of eukaryotic polypeptides synthesized in Escherichia coli.//Biochem J. 1986. V.240(l). P. l-12.
- Middelberg A.P.J. / Preparative protein refolding // Trends Biotech. 2002. V.20(10). P.437−443.
- Taylor G., Hoare M, Gray D. R., Marston F. A. O. / Size and density of protein inclusion bodies // Bio/Technol 1986. V.4. P.553−557.
- Schein С. / Solubility as a function of protein structure and solvent components // Biotechnology (NY). 1990. V.8(4). P.308−317.
- Staehelin Т., Hobbs D. S., Kung H.-F., Pestka S. / Purification of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies // Methods Enzymol. 1981. V.78(Pt A). P.505−512.
- Misawa S., Kumagai L / Refolding of therapeuyic proteins produced in Escherichia coli as inclusion bodies // Biopolimers (Peptide Science) 1999. V.51. Р.297−307/
- Л.И. Патрушев / Искусственные генетические системы, т.1 Генная и белковая инженерия // М: «Наука». 2004.
- Ming Li, Zhi-Guo Su, and Janson J.-C. / In vitro protein refolding by chromatographic procedures // Protein Expression and Purification 2004. V.33. P. l-10.
- Mukhopadhyay A. / Inclusion bodies and purification of proteins in biologically active forms. //Adv Biochem Eng Biotechnol. 1997. V.56. P.61−109.
- Fischer, В.- Sumner, /.- Goodenough, P. / Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. // Biotechnol Bioeng. 1993. V.41(l). P.3−13.
- Datar, R. V.- Cartwright, Т.- Rosen, C.-G. / Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator//Biotechnology (N Y) 1993. V. ll (3). P.349−357.
- Gross, G.- Hollatz, I. / Coliphage lambda to terminator lowers the stability of messenger RNA in Escherichia coli hosts // Gene 1988. V.72(l-2). P.119−128.
- Sowers G., Jarsch M. / Alternative regulation principles for the production of recombinant proteins in Escherichia coli // Appl Microbiol Biotechnol. 1996. V.46(l). P.1−9.
- GoldL., Stormo G. D. / High-level translation initiation // Methods En-zymol. 1990. V.185. P.89−93.
- Gottesman S. / Minimizing proteolysis in Escherichia coli: genetic solutions // Methods Enzymol. 1990. V.185. P. l 19−129.
- Nygren P.-A., Sthl S., Uhlen M. / Engineering proteins to facilitate bio-processing//Trends Biotechnol. 1994. V.12(5). P.184−188.
- Schein C. / Solubility as a iiinction of protein structure and solvent of protein structure and solvent components. // Bio/Technology 1990. V.8. P.308−317/
- Kane J. F., and Hartley D. L. / Formation of recombinant protein inclusion bodies in Escherichia coli // Tibtech 1988. V.6. P.95−101.
- Wilkinson D. L., and Harrison R. G. / Predicting the solubility ofrecom-binant proteins in Escherichia coli. // Bio/Technology 1991. V.9. P.443−448.
- Gribskov M. and Burgess R. R. / Overexpression and purification of the sigma subunit of Escherichia coli RNA polymerase. // Gene 1983. V.26. P.109−118
- Kiefliaber T., Rudolph R., Kohler H.-H., and Buchner J. / Protein aggregation in vitro and in viva: a quantitative model of the kinetic competition between folding and aggregation. //Bio/Technology 1991. V.9. P.825−829.
- Kopetzki, E., Schumacher, C., and Bucket, P. / Control of formation of active soluble or inactive insoluble baker’s yeast alpha-glucosidase PI in Escherichia coli by induction and growth conditions. // Mol. Gen. Genet. 1989. V.216. P.149−155.
- Cabilly S. / Growth at sub-optimal temperatures allows the production of functional antigen-binding Fab fragments in Escherichia coli. // Gene 1989. V.85. P.553−557.
- Fahey R. C., Hunt, J. S. and Windham, C. C. / On the cysteine and cystine content of proteins. Differences between intracellular and extracellular proteins. // J. Mol. Evol. 1977. V.10. P.155−163.
- Rudolph R., and Fuch, 1. / Influence of glutathione on the reactivation of enzymes containing cysteine. // Hoppe-Seyler's Z. Physiol. Chem. 1983. V/364. P.813−820.
- Derman A. I., Prinz W., Belin D., andBeclcwith J. / Mutations that allow disulfide bond formation in the cytosol of Escherichia coli. // Science 1993. V.262. P. 1744−1747.
- Skerra A., and Pluckthun A. / Assembly of a functional immunoglobulini
- Fv fragment in Escherichia coli. // Science 1988. V.240. P.1038−1042.
- Pluckthun A. / Antibody engineering: Advances from the use of Escherichia coil expression systems. // Bio/Technology 1991. V.9. P.545−551.
- Bardwel, J. C. A., McGovem K., and Beckwith J. / Identification of a protein required for disulfide bond formation in viva. // Cell 1991. V.67. P.581−589.
- Missiakas D., Schwager F., and Raina S. / Identification and characterization of a new disulfide isomerase-like protein (DsbD) in Escherichia coli. // EMBO J. 1995. V.14. P.3415−3424.
- Rudolph R. / Successful protein folding on an industrial scale. In Protein Engineering: Principles and Practices // (Cleland J. L., and Craik Ch. S., eds) John Wiley & Sons (NY) P.283−298.
- Kuhelj R., Dolinar M., Pungerrcar J., and Turk V. / The preparation of catalytical active human cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies. // Eur. J. Biochem. 1995. V.229. P.533−539.
- Hejnaes K. R., Bayne S., Norskoy L., Sorensen H. H., Thomsen J., Schaff er L., Wollmer A., and Skriver L. / Development of an optimized refolding process for recombinant Ala-Clu-IGF-1. // Protein Eng. 1992. Y.8. P.797−806.
- Vallejo L.F., Rinas U. / Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins // Microbial Cell Factories 2004. V.3 P. l 1.
- Hart R. A., Rinse U., and Bailey J. E. / Protein composition of Vitreo-sciiia hemoglobin inclusion bodies produced in Escherichia coli. // J. Biol. Chem. 1990. V.265. P.12 728−12 733.
- Valax P. and Georgiou G. / Molecular characterization of beta-lactamase inclusionbodies produced in Escherichia coli. 1. Composition. // Biotechnol. Prog. 1993. V.9. P.539−547.
- Oberg K., ChrunykA., Wetzel R., and Fink A. / Native-like secondary structure in interleukin-1 inclusion bodies by attenuated total reflectance FTIR. //Biochemistry 1994. V.33. P.2628−2634.
- Przybycien T. M., Dunn J. P., Valax, P. and Ceorgiou, C. / Secondary structure characterization of -lactamase inclusion bodies. // Protein Eng. 1994. V.l.P.131−136.
- Hagel P., Gerding J.J. T., Fieggen W., Bloemendal H. / Cyanate formation in solutions of urea I. Calculation of cyanate concentrations at different temperature and pH. // Biochim Biophys Acta 1971. V.243. P.366−373.
- Cejka J., Vodrazka Z, SalakJ. / Carbamylation of globin in electrophoresis and chromatography in the presence of urea. // Biochim Biophys Acta 1968. V.154. P.589−591.
- Iwakura M., Ohara K, Kokubu T., Ohashi S., Izutsu H. / Expression and purification of growth hormone-releasing factor with the aid of dihydrofolate reductase handle. //J Biochem (Tokyo) 1992. V.112. P57−62.
- Patra A.K., Mukhopadhyay R., Mukhija R., Krishnan A., Garg L. C., Panda A.K. / Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. // Protein Expr Purif 2000. V.18. P.182−192.
- Thatcher D.R., Hitchcock A. / Protein folding in biotechnology. In Mechanisms of protein refolding Edited by: Pain HR. // Oxford: Oxford University Press 1994. P.229−254.
- Stockei J., Doring K., MalotkaJ., J ahnig F., Dornmair K. I Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. // Eur J Bio- • chem. 1997. V.248(3). P.684−691.
- Cardamone M., Puri N.K., Brandon M.R. / Comparing the refolding and reoxidating of recombinant porcine growth hormone from a urea denaturated state and from Escherichia coli inclusion bodies // Biochemistry 1995. V.34. P.5773−5794.
- Puri N. K. et. al. / Solubisation of growth hormone and other recombinant proteins from Escherichia coli inclusion bodies by using a cationic surfactant// Biochem. J. 1992. V.285. P.871−879.
- Burgess R.R. / Purification of overproduced Escherichia coli RNA polymerase sigma factors by solubilizing inclusion bodies and refolding from sar-cosyl // Methods Enzymol. 1996. V.273. P.145−149.
- Gierasch L.M., Lacy J.E., Thompson K.F., Rockwell A.L., Watnick P.I. / Conformations of model peptides in membrane-mimetic environments // Bio-phy. J. 1982. V.37. P.275−284.
- Tsumoto K., EjimaD., Kumagai I., Arakawa T. / Practical considerations in refolding proteins from inclusion bodies // Protein Expression and Purification 2003. V2.8. P. l-8.
- Bhavesh N.S., Panchal S. C., Mittal R., Hosur R. V. / NMR identification of local structure preferences I HIV protease tethered heterodimer in 6M gua-nidine hydrochloride // FEBS Lett. 2001. V.509. P.218−224.
- Arakawa T., Philo J., Kenney W.C. / Structure and solubility of inter-leukin-2 in sodium dodecyl sulfate // Int. J. Pept. Protein Res. 1994. V.43. P.583−587.
- SchoemakerJ. M, Brasnett A. H., and Marston F. A. O. / Examination of calf prochymotrypsin accumulation in Escherichia coli: disulphide linkages are a structural component of prochymotrypsmn-containing inclusion bodies. // EMBO J. 1985. V.4. P.775−780.
- Hart R. A., Lester P. M., Reifsnyder D. H" Ogez J. R., and Builder S. E. / Isolation of non-native ICF-I by aqueous two-phase extraction. // Bio/Technology 1994. V.12. P. l 113−1117.
- Jaenicke R., Rudolph R., andHeider I. / Specificity in the subunit assembly of oligomeric enzymes. Synchronous reconstitution of mammalian lactic and malic dehydrogenases. // Biochem. Int. 1981. V.l. P.23−31.
- Maachupalli-Reddy J., Kelley B.D., De Bernardez Clark E. I Effect of inclusion body contaminants on the oxidative renaturation of hen egg white ly-sozyme. //Biotechnol. Prog. 1997. V.13. P. 144−150.
- Tran-Moseman A., Schauer N., De Bernardez ClarkE. / Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor. // Protein Expr. Purif. 1999. V.16. P. 181−189.
- Thatcher D.R., Hitchcock A. / Protein folding in biotechnology. In Mechanisms of protein refolding Edited by: Pain HR. // Oxford: Oxford University Press. 1994. P.229−254
- Hochuli E., Dobeli H and Schacher A. / New metal chelate adsorbent selective for proteins and peptides containing neighboring histidine residues. // J. Chromatography 1987. V.411. P. 177−184.
- Maeda Y., Koga H., YamadaH., Ueda T., Imoto T. / Effective renaturation of redused lysozyme by gentle removal of urea // Protein Eng., 1995. V.8. P.201−205.
- WestS.M., Chaudhari J.B., Howell J.A. / Improved protein refolding using hollow-fibre membrane dialysis // Biotechnol. Bioeng.1998. Y.57. P.590−599.
- Yoshii H., Furuta T., Yonehara T., Ito D., Linko Y.-Y., Linko P. / Refolding of denaturated/redused lysozyme at high concentration with diafiltration // Biosci. Biotechnol. Biopchem. 2000. V.64. P. 1159−1165.
- Varnerin J.P., Smith T., Rosenblum C.I., Vongs A., Murphy B.A., Nunes C., Meilin T.N., King J. J., Burgess B. V. / Production of leptin in Escherichia coli: a comparison of methods // Protein Expr. Purif. 1998. V.14. P.335−342.
- UmetsuM., Tsumoto K., HaraM., Ashish K., Goda .S, Adschiri T., Ku-magai I. / How Additives Influence the Refolding of Immunoglobulin-folded Proteins in a Stepwise Dialysis System // The Journal Of Biological Chemistry 2003. V.278. No.ll. P.8979−8987.
- West S.M., Chaudhuri J.B., Howell J.A. / Improved protein refolding using hollow-fibre membrane dialysis // Biotechnol. Bioeng. 1998. V.57. P.590−599.
- Hevehan D.L., Clark E.B. / Oxidative renaturation of lysozyme at high concentrations //Biotechnol. Bioeng. 1997. V.54. P.221−230.
- Hamada K,. Shiraki / L-Argininamide improves the refolding more effectively then L-arginine // Journal of Biotechnology 2007. V.130. P.153−165.
- Winter J., Lilie H., Rudolph R. / Recombinant expression and in vitro folding of pro insulin are stimulated by the synthetic dithiol Vectrase-P // FEMS Microbiology Letters 2002. V.213. P.225−230.
- Katoh S., Katoh Y. / Continuous refolding of lysozyme with fedbatch addition of denatured protein solution // Process Biochem. 2000 V.35. P. 11 191 124./
- Winter J., Lilie H., and Rudolph RJ Renaturation of human proinsulin—a study on refolding and conversion to insulin // Analytical Biochemistry 2002. V.310. P.148−155.
- De Bernardez Clark E., Schwarz E., Rudolph R. / Inhibition of aggregation side reactions during in vitro protein folding // Methods Enzymol 1999. V.309. P.217−236.
- Amons R., Schrier P. L / Removal of sodium dodecyl sulfate from proteins and peptides by gel filtration // Anal. Biochem. 1981. V. l 16. P .439−443.
- Werner M.H., Clore G.M., Gronenborn A. M, Kondoh A., Fisher R.J. / Refolding proteins by gel filtration chromatography // FEBS Lett. 1994. V.345. P.125−130.
- Batas B., Chaudhuri J.B. / Protein refolding at high concentration using size-exclusion chromatography // Biotechnol. Bioeng. 1996. V.50. P. 16−23.
- Batas B., Chaudhuri J.B. / Consideration of sample application and elu-tion during size-exclusion chromatography-based protein refolding // J. Chromatogr. A 1999. V.864. P.229−236.
- Batas B., Jones H.R., Chaudhuri J.B. / Studies of the hydrodynamic volume changes that occur during refolding of lysozyme using size-exclusion chromatography // J. Chromatogr. A 1997. V.766. P.109−119.
- Fahey E.M., Chaudhuri J.B. / Molecular characterization of size exclusion chromatography refolded urokinase-plasminogen activator // Chem. Eng. Sci. 2001. V.56. P.4971−4978.
- Gu Z., Su Z., Janson J.-C. / Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding // J. Chromatogr. A 2001. V.918.1. P.311−318.
- GuZ., Weidenhaupt M., Ivanova N., Pavlov M, Xu B" Su Z., Janson J.-C. / Chromatographic methods for the isolation of, and refolding of proteins from Escherichia coli inclusion bodies // Protein Expr. Purif. 2002. V.25.1. P. 174−179.
- Lanckriet H., Middelberg A.P.J. / Continuous chromatographic protein refolding // Journal of Chromatography A 2004. V.1022. P. 103−113.
- Orsini G., Goldberg M.E. / The renaturation of reduced chymotrypsino-gen A in guanidine-HCl // J. Biol. Chem. 1978. V.253. P.3453- 3458.
- Epstein C.J., Anfinsen C.B. / The reversible reduction of disulfide bonds in trypsin and ribonuclease coupled to carboxymethyl cellulose // J. Biol. Chem. 1962. V.237. P.2175−2179.
- Light A.L. / Protein solubility, protein modifications, and protein folding // Bio/Techniques 1983. V.3. P.298−305.
- Stempfer G, Holl-Neugebauer B, Kopetzki E, Rudolph R. / Improved refolding of an immobilised fusion protein //Nat. Biotechnol. 1996. V.14. P.329−334.
- Kogl H., Kosemund K., Kufehlbrandt W., Collinsonl. / Refolding of Escherichia coli produced membrane protein inclusion bodies immobilized by nickel chelating chromatography // FEBS Lett. 1998. V.432. P.21−26.
- Berdichersky Y., Lamed R., Frenkel D., Gphna V., Bayer E.A., Yaron S., Shoham Y., Benharl. / Matrix-assisted folding of singlechain Fv cellulose binding domain fusion proteins // Protein Expr. Purif. 1999. V.17. P.249−259.
- Creighton T.E. / Folding of proteins adsorbed reversibly to ionexchange resins, in: D.L. Oxender (Ed.): UCLA Symposia on Molecular and Cellular Biology New York, 1986. V.39. P.249−257.
- Guo L. / Simultaneous purification and renaturation of recombinant human interferon alpha expressed by E. coli by highperformance hydrophobic interaction chromatography // Chin. J. Chromatogr. 2001. V.19. P.301−303.
- LingM., XuX., Shi F., Zhu Y., LongN. / Refolding of recombinant human interleukin-2 by reverse phase high performance liquid chromatography //Chin. J. Biotechnol. 1997. V. 13. P. 180- 183.
- Zouhar J., Nanak E., Brzobohaty B. / Expression, single-step purification, and matrix-assisted refolding of a maize cytokinin glucoside-specific b-glucosidase//Protein Expr. Purif. 1999. V.17. P.153−162.
- Li M, Zhang G.F., Su Z. / Dual gradient ion-exchange chromatography improved refolding yield of lysozyme // J. Chromatogr. A 2002. V.959.1. P. l 13−120.
- Misawa S., Aoshima M., Takaku H., Matsumoto M., Hayashi H. / Highlevel expression of mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme // J. Biotechnol. 1994. V.36.1. P.145−155/
- Cleland J. L / Impact of protein folding on biotechnology // in: J.L. Cle-land (Ed.) Protein Folding: In Vivo and In Vitro American Chemical Society Washington 1993. P. 1−21.
- Baneyx F. / Recombinant protein expression in Escherichia coli // Curr. Opin. Biotechno1. 1999. V.10. P.411−421.
- Mayer M., Kies U., Kammermeier R., Buchner J. / BIP and PDI cooperate in the oxidative folding of antibodies in vitro // J. Biol. Chem. 2000., V.275. P.29 421−29 425.
- DongX., Yang H., Sun Y. / Lysozyme refolding with immobilized GroEL column chromatography // J. Chromatogr. A 2000. V.878. P. 197−204.
- Altamirano M.M., Garcia C., Possani L.D., Fersht A. / Oxidative refolding chromatography: folding of the scorpion toxin Cn5 I I Nature Biotechnol. 1999. V.17. P. 187−191.
- Carlson J.D., Yarmush M.L. / Antibody assisted protein refolding // Bio/Technology 1992. V.10. P.86−91.
- Rudolph, R. / Renaturation of recombinant, disulfide-bonded proteins from inclusion bodies // In Modern Methods in Protein and Nuckic Acid Research (Tschesche, H., ed) 1990. P. 149−172.
- Sela M., White F. H., and Anfinsen C. B. / Reductive cleavage of disulfide bridges in ribonuclease. // Science 1956. V.16. P.691−692.
- Ahmed A. K, Schajfer S. W, and Wetlaufer D. B. / Noenzymatic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers // J. Biol. Chem. 1985. V.250. P.8477−8482.
- Wetlaufer D. B., Branca P. A., and Chen G.-X. / The oxidative folding of proteins by disulfide plus thiol does not correlate with redox potential // Protein Eng. 1987. V.2. P.141−146.
- Fischer S., Rudolph R., and Mattes R. I European Patent Application, Patent No.0393 725 A 1. 1986.
- DiBella E. E., Maurer M. C., and Scheraga H. A J Expression and folding of recombinant bovine prethrombin-2 and its activation to thrombin // J. Biol. Chem. 1995. V.270. P.163−169.
- Kuhelj R., Dolinar M, Pungerrcar J., and Turk V. / The preparation of catalytical active human cathepsin B from its precursor expressed in Escherichia coli in the form of inclusion bodies // Eur. J. Biochem. 1995. V.229. P.533−539.
- Vallejo L.F., Rinas U. / Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration // Biotechnol Bioeng 2004. V.85. P.601−609.
- Midler C., Rinas U. / Renaturation of heterodimeric platelet-derivedgrowth factor from inclusion bodies of recombinant Escherichia coli usingsize-exclusion chromatography // J Chromatogr A 1999. V.855. P.203−213.
- Privalov P.L. / Physical basis of the stability of the folded conformations of proteins // In Protein folding Edited by: Creighton T.E. New York: W. H. Freeman and Company 1992. P/83−126.
- Robinson C.R., Sligar S.G. / Hydrostatic and osmotic pressure as tools to study macromolecular recognition // Methods Enzymol. 1995. V.259. P.395−427.
- FoguelD., Robinson C.R., de Sousa P.C. Jr., Silva J.L., Robinson A.S. / Hydrostatic pressure rescues native protein from aggregates // Biotechnol Bioeng 1999. V.63. P.552−558.
- St John R.J., Carpenter J.F., Randolph T.W. / High pressure fosters protein refolding from aggregates at high concentrations // Proc Natl Acad Sei USA 1999. V.96. P.13 029−13 033.
- St John R.J., Carpenter J.F., Balny C., Randolph T. W. / High pressure refolding of recombinant human growth hormone from insoluble aggregates: Structural transformations, kinetic barriers and energetics // J Biol Chem 2001. V.276. P.46 856−46 863.
- Builder S., and Ogez J. R. / United States Patent Application 4620 948. 1986.
- Orsini C., and Goldberg M. E. / The renaturation of reduced chy-motrypsinogen A in guanidine HCL Refolding versus aggregation/ J. Biol. Chem. 1978. V.253. P.34−39.
- Yasuda M, Murakami Y., Sowa A., Ogino K, and Ishikawa H. / Effect, of Additives on Refolding of a Denatured Protein // Biotechnol. Prog. 1998. V.14. P.601−606.
- Cleland J.L.,. Wang D.I. C. / Cosolvent assisted protein refolding // Biotechnology 1990. V.8. P.1274−1278.
- Karuppiah N., Sharma A. / Cyclodextrins as protein folding aids // Bio-chem. Biophys. R. 1995. V.211. P.60−66.
- Arora D., Khanna N., / Method for increasing the yield of properly folded recombinant y-interferon from inclusion bodies // J. Biotechnol. 1996. V.52. P.127−133.
- Suenaga M., Ohmae H., Tsuji S., Itoh T., Nishimura O. / Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation // Biotechnol. Appl. Biochem. 1998. V.28. P. 119−124.
- Arakawa T. and Tsumoto K. / The effects of arginine on refolding of aggregated proteins: Not facilitate refolding, but suppress aggregation // Biochem. Biophys. Res. Comm. 2003. V.304. P.148−152.
- Reddy K.R.C., Lilie H., Rudolph .R, Lange C. / L-Arginine increases the solubility of unfolded species of hen egg white lysozyme // Protein Sei. 2005. V.14. P.929−935.
- Rudolph R., Fischer S., and Mattes R. / Process for the activation of t-PA or Ing after genetic expression in prokaryotes // U.S. patent 5,453,363 1995.
- Kudou M., Shiraki K., Fujiwara S., Imanaka T., Takagi M. / Prevention of thermal inactivation and aggregation of lysozyme by polyamines // Eur. J. Biochem. 2003. V.270. P.4547−4554.
- Ou W.B., Park Y.D.,. Zhou H.M. / Effect of osmolytes as folding aids on creatine kinase refolding pathway // Int. J. Biochem. Cell Biol. 2002. V.34. P.136−147.
- Meng F., Park Y., Zhou H. / Role of proline, glycerol, and heparin in protein folding aids during refolding of rabbit muscle creatine kinase // Int. J. Biochem. Ceil Biol. 2001. V.33. P.701−709.
- ClelandJ. L., Hedgepeth C., and Wang D. I. C. / Polyethylene glycol enhanced refolding of bovine carbonic anhydrase B // J. Biol. Chem. 1992. V.267. P.13 327−13 334.
- Buchner J., and Rudolph R. / Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli // Bio/Technology 1991, V.9. P.157−161.
- Taneja S., and Ahmad F. / Increased thermal stability of proteins in the presence of amino acids //Biochem. J. 1994. V.303. P.147−153.
- Rudolph R., Lilie H. / In vitro folding of inclusion bodies protein // FASEB J. 1996. V.10. P.49−56.
- Ambrosius D., and Rudolph R. / European Patent Application No. WO 92/9 622. 1992.
- Tandon S., and Horowitz P. M. / Detergent-assisted refolding of gua-nidmnium chloride-denatured rhodanese // J. Boil. Chem. 1987. V.262. P.4486−4491.
- CerlettiN., McMaster C., Cox D., SchmitzA., MeyhackB. / European Patent Application No.0433 225 Al. 1990.
- Zardeneta C., and Horowitz P. M. / Protein refolding at high concentrations using detergent/phospholipid mixtures // Anal. Biochern. 1994. V.218. P.392−398.
- Rozena D., and Gellma S. H. / Artificial chaperones: Protein refolding via sequential use of detergent and cyclodcxtrin // J. Am. Chem. Soc. 1995. V.117. P.2373−2374.
- Cooper A. / Effect of cyclodextrins on the thermal stability of globular proteins//J. Am. Chem. Soc. 1992. V.114. P.9208−9214.
- Lange K., Patil G., Rudolph R. / Ionic liquids as refolding additives: N.-alkyl and N.-(v-hydroxyalkyl) N-methylimidazolium chlorides // Protein Science 2005. V.14. P.2693−2701.
- Summers C.A. and Flowers R.A. / Protein renaturation by the liquid organic salt ethylammonium nitrate. // Protein Sci. 2000. V.9. P.2001−2008.
- Dabora J. M, Sanyal C., andMiddaugh C. R. / Effect of polyanions on the refolding of human acidic fibroblast growth factor // J. Biol. Chem. 1991. V.266. P.23 637−23 640.
- Carlson J. D., and Yarmush M. I. / Antibody assisted protein refolding // Bio/Technology 1992. V.10. P.86−91.
- Ewalt K.L., Hendrick J.P., Houry W.A., Hartl F. U. / In vivo observation of polypeptide flux through the bacterial chaperonin system // Cell 1997. V.90. P.491−500.
- Thomas J.G., AylingA., BaneyxF. / Molecular chaperones, folding catalysts, and the recoverey of active recombinant proteins from E. coli // Appl Biochem Bioiechnol 1997. V.66. P. 197−238.
- Buchner J., Brinkmann U., Pastan I. / Renaturation of a single-chain immunotoxin facilitated by chaperones and protein disulfide isomerase // Bio/Technology 1992. V.10. P.682−685.
- Machida S., Ogawa S., Xiaohua S., Takaha Т., Fujii K., Hayashi K. / Cycloamylose as an efficient artificial chaperone for protein refolding // FEBS Lett 2000. V.486. P.131−135.
- Simon S.M., Peskin C.S., Oster G.F. /What drives the translocations of proteins // Proc Natl Acad Sci USA 1992. V.89. P.3770−3774.
- Yoshii II., Furuta Т., Yasunishi A., Kojima, T. / Rapid renaturation of denatured and aggregated proteins using liquid paraffin as a pseudolipid bi-layer membrane//Biotechnol Bioeng 1994. V.43. P.57−63.
- Frank S.H., Pettee J.M., Zimmerman R.E. and Burck P.J. in: Peptides: Proceedings о f the Seventh American Peptide Chemistry Symposium 1981. P.729−738.
- Williams D.C., Van Frank R.M., Muth W.L. and Burnett J.P. / Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins // Science. 1982. V.215(4533). P.687−903.
- Sung. W.L., Yau, F.L., Zahab, D. M, andNarang, S.A. / Short synthetic oligodeoxyribonucleotide leader sequences enhance accumulation of human proinsulin synthesized in Escherichia coli. // Proc. Natl. Acad. Sci. USA 1986. V.83. P.561−565.
- Cowley D. J., Maskin R.B. / Expression, purification and characterization of recombinant human proinsulin // FEBS Lett. 1997. V.402. P.124−130.
- Иванкин A.H., Миталева С. И., Неклюдов А. Д. // Биосинтез и выделение рекомбинантного белка с целью получения генно-инженерного проинсулина человека // Прикладная биохимия и микробиология 1998. т.34. № 3. с.293−299.
- Obermeier et al. / Process for converting preproinsulin analogs into insulins // United States Patent #4.639.333 1987.
- Chan S.G. / Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli // PNAS 1981. V.78. № 2. P.5401−5405.
- Brousscau R., Scarpulla R., Sung W. V. / Enzymatic assembly, cloning and characterization of the human proinsulin DNA // Gene 1982. V.17. № 3 P. 279−289.
- Навашин C.M. и др. / Инсулин человека: физико-химические свойства и получение // Антибиотики и химиотерапия 1988. т.23. № 9. с.701−708.
- GuoL.H., Stepien P.P., TsoJ.Y., Brousseau R., NarangS., Thomas D.Y., Wu R. / Synthesis of a human insulin gene VIII. Construction of expression vectors for fused proinsulin production in Escherichia coli // Gene 1984. V.29. №½. P.251−254.
- Mackin R.B. / Streamlined procedure for the production of normal and altered version of recombinant human proinsulin // Protein Expression and Purification 1999. V.15. P.308−313.
- Chance R .E. and Frank B. / Research, development, production, and safety of biosynthetic human insulin. // Diabetes Care Suppl. 1993. V.3.1. P.133−142.
- Nilsson J., Jonasson P., Samuelsson E., Stahl S., Uhlen M. / Integrated production of human insulin and its C-peptide // Journal of Biotechnology 1996. V.48. P.241−250.
- Dai Y., Tang J.G. I Intra-A chain disulfide bond (A6−11) of insulin is essential for displaying its activity // Biochem. Mol. Biol. Int. 1994. V.33. P.1049−1053.
- Ю.М. Торчинский / Сера в белках // М: Наука 1977
- Winter J., Klappa P., Freedman R.B., Lilie H. and Rudolph R. / Catalytic activity and chaperone function of human protein disulfide isomerase are required for the efficient refolding of proinsulin // J. Biol. Chem. 2002. V.277. P.310−317.
- Winter J., Neubauer P., Glockshuber R., Rudolph R. / Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA // Journal of Biotechnology 2000. V.84. P.175−185.
- Иванкин A.H., Миталева С. И., Неклюдов А. Д. / Биосинтез и выделение рекомбинантного белка с целью получения генно-инженерного проинсулина человека // Прикладная биохимия и микробиология 1998. т.34. № 3. с.293−299.
- Petrides D., SapidouE., Calandranis J. / Computer-aided process analysis and economic evaluation for biosynthetic human insulin production -a case study // Biotechnology and Bioengineering 1995. V.48. P.529−541.
- Chang S. G., Kim D. Y, Choi K.D., Shin J.M., Shin H. C. / Human insulin production from mini-proinsulin which has high receptor-binding activity // Biochem. J. 1998. V.329. P.631−635.
- Oliva A., Farina J., Llabres N. J. / Development of two highperformance liquid chromatographic methods for the analysis and characterization of insulin and its degradation products in pharmaceutical preparations. // Chromatogr. В 2000. V.749. P.25−28.
- BrangeJ., Havelund S., Hougaard P. / Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. // Pharm Res. 1992. V.6. P.727−734.
- Клюшниченко В. E., Вульфсон A. H. / Генно-инженерный инсулин человека. II. Эксклюзионная ВЭЖХ биотехнологических предшественников. Факторы, влияющие на разрешение и селективность // Биоорг. химия 1993. т. 19. № 2ю с.174−181.
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Text and Methodology (Q2(R1)), Geneva2005.
- Guidance for industry: Bioanalytical method validation / US Department of Health and Human Services, Food and Drug Administration, Rock-ville MD May 2001.
- The United States Pharmacopeia, Philadelphia PA USA 2000 (USP24) Suppl. 3.
- Rudolph R. et al. / Folding proteins, p. 57−99 in Creighton T.E.Protein function, a practical approach I I IRL-Press, Oxford University Press Oxford 1997.
- Chen J., Liu Y., LiX., Wang Y" Ding H., Ma G, Su Z. / Cooperative effects of urea and 1-arginine on protein refolding // Protein Expression and Purification 2009. V.66.1.1. P.82−90.
- Hamada H., Shiraki K./ L-Argininamide improves the refolding more effectively than 1-arginine // Journal of Biotechnology 2007. V.130.1.2.1. P.153−160.
- Singh S. M., Panda A.K. / Solubilization and refolding of bacterial inclusion body proteins // Journal of Bioscience and Bioengineering 2005. V.99. 1.4. P.303−310.